Transcriptomic and Functional Screens Reveal MicroRNAs That Modulate Prostate Cancer Metastasis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Metastasis is a critical, fatal step in prostate cancer (PCa) progression.
• Small non-coding RNAs, particularly microRNAs, are increasingly recognized as key regulators of tumor cell biology and metastasis.
• Understanding the role of microRNAs in PCa metastasis is vital for developing effective therapeutic strategies.

Purpose of the Study:

• To elucidate the contribution of microRNAs to prostate cancer metastatic progression.
• To identify specific microRNAs that modulate cancer cell migration and morphology.
• To integrate transcriptomic data with functional screening to discover clinically relevant microRNAs in PCa.

Main Methods:

• Development of high-content microscopy and high-throughput functional screens for cell migration and morphology using a microRNA library in PCa cells.
• RNA-sequencing (RNA-Seq) analysis of paired epithelial and mesenchymal PCa cells to identify differentially expressed microRNAs.
• Integration of transcriptomic data with functional screening results and analysis of published PCa patient datasets.

Main Results:

• RNA-Seq identified differential expression of 200 microRNAs between epithelial and mesenchymal PCa cells.
• Data integration pinpointed two microRNAs that significantly inhibited cell migration and induced an epithelial-like morphology.
• These identified microRNAs were found to be upregulated in epithelial PCa cells, with a notable overrepresentation of the AAGUGC seed sequence across datasets.

Conclusions:

• The study successfully integrated high-throughput functional and expression analyses to identify microRNAs with clinical significance in PCa.
• Identified microRNAs modulate metastatic behavior, offering potential as therapeutic targets for prostate cancer.
• The findings highlight the clinical relevance of specific microRNAs in regulating PCa cell metastasis.